Contact Support
Pen needles
Take comfort in our needles
BD pen needles leverage advanced technology, innovative design and state-of-the-art manufacturing. Compatible with leading diabetes medication pens in Canada and tested in accordance with ISO standards for compatibility, our pen needles start as flat pieces of surgical steel that then are rolled into tubes. This design promotes injection comfort in a 4-mm size.1
BD pen needles incorporate the following methods to optimise injection comfort:
- Penta Point™ Comfort technology. After cutting the cannula to length, we shape the needle tip into a patented five-bevel design, which promotes more comfortable and easier insertion compared to a three-bevel needle.
- Microbonded lubrication. We add a layer of microbonded lubrication while manufacturing the needle to help the needle more smoothly glide into skin.
- Electropolishing. We use a manufacturing process that polishes the needle to a smooth finish, removing the very small blemishes and rough spots that could otherwise occur during manufacturing and cause painful skin tearing.2
BD AutoShield Duo™ pen needle
The BD AutoShield Duo pen needle is a 5-mm pen needle that enables a wide variety of clinical and patient benefits in insulin injection.
BD Nano PRO™ 4mm pen needle
The BD Nano PRO™ redesigned to make injections easier from start to finish.
BD Nano™ 4mm pen needle
The BD Nano 4mm pen needle features two technologies that optimise the insulin injection experience.
BD Ultra-Fine™ Pen Needles
BD Ultra-Fine™ Pen needles are available in 4 mm, 5 mm, 6 mm, 8 mm and 12.7 mm lengths.
Please note, not all products, services or features of products and services may be available in your local area. Please check with your local BD representative.
References
- Hirsch L, Gibney M, Berube J, Manocchio J. Impact of a modified needle tip geometry on penetration force as well as acceptability, preference and perceived pain in subjects with diabetes. J Diabetes Sci Technol. 2012;6(2):328-335.
- Look D. Reuse of sharps in diabetic patients: Is it completely safe? Diabetes J. 1998;10:31-34.
1000-BDW-CA-EN-00534